Assenagon Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-517,576
Closed -$1.01M 1200
2026
Q1
$1.01M Buy
517,576
+379,546
+275% +$890K ﹤0.01% 892
2025
Q4
$374K Sell
138,030
-16,075
-10% -$52.8K ﹤0.01% 1074
2025
Q3
$652K Sell
154,105
-103,475
-40% -$455K ﹤0.01% 1006
2025
Q2
$1.28M Sell
257,580
-105,133
-29% -$457K ﹤0.01% 877
2025
Q1
$1.6M Buy
362,713
+39,337
+12% +$185K ﹤0.01% 808
2024
Q4
$1.5M Sell
323,376
-62,044
-16% -$341K ﹤0.01% 1018
2024
Q3
$2.67M Sell
385,420
-639,205
-62% -$5.02M ﹤0.01% 870
2024
Q2
$7.99M Hold
1,024,625
0.02% 488
2024
Q1
$7.27M Sell
1,024,625
-325,175
-24% -$2.15M 0.02% 507
2023
Q4
$9.04M Buy
1,349,800
+99,072
+8% +$558K 0.02% 479
2023
Q3
$7.04M Buy
1,250,728
+75,690
+6% +$505K 0.02% 482
2023
Q2
$6.49M Buy
1,175,038
+44,987
+4% +$242K 0.02% 440
2023
Q1
$7.06M Buy
+1,130,051
New +$6.3M 0.03% 478
2022
Q4
Sell
-581,820
Closed -$2.72M 1393
2022
Q3
$2.72M Buy
581,820
+24,595
+4% +$155K 0.01% 626
2022
Q2
$3.3M Buy
+557,225
New +$6.2M 0.01% 674
2022
Q1
Sell
-483,592
Closed -$15.8M 1470
2021
Q4
$15.8M Buy
+483,592
New +$19.5M 0.05% 238

Other funds holding GDRX

Assenagon Asset Management's GDRX Position: Q2 2026 in Review

Assenagon Asset Management sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 517,576 shares — an estimated $1.01M sold.

Assenagon Asset Management first reported a position in GDRX in Q4 2021 and held it in 16 quarters. The position peaked at $15.8M in Q4 2021. 6 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Assenagon Asset Management reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • Assenagon Asset Management sold 517,576 GoodRx Holdings shares in Q2 2026, an estimated $1.01M.
  • Assenagon Asset Management first reported a position in GoodRx Holdings in Q4 2021 and held it in 16 quarters.
  • Assenagon Asset Management's GoodRx Holdings position peaked at $15.8M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.